Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.44% | 72.43 | 0.9% | $622.43m | |
| CELG | Celgene Corporation | 0.29% | 128.02 | 1.1% | $446.62m | |
| AMGN | Amgen Inc. | 0.39% | 167.94 | 1.1% | $420.10m | |
| BIIB | Biogen Inc. | 0.30% | 282.62 | 1.2% | $357.46m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.55% | 470.56 | 2.7% | $323.60m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.70% | 149.17 | 1.9% | $266.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.15% | 134.93 | 1.9% | $220.47m | |
| ILMN | Illumina, Inc. | 0.35% | 189.99 | 3.5% | $217.12m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.38% | 36.84 | 19.8% | $138.97m | |
| INCY | Incyte Corporation | -1.00% | 119.98 | 2.6% | $129.64m | |
| CLVS | Clovis Oncology, Inc. | 0.21% | 72.11 | 18.0% | $129.47m | |
| KITE | Kite Pharma, Inc. | 1.60% | 132.26 | 16.1% | $123.79m | |
| TSRO | TESARO, Inc. | 0.69% | 114.65 | 14.7% | $122.53m | |
| A | Agilent Technologies, Inc. | 0.49% | 61.55 | 1.5% | $119.61m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.30% | 81.16 | 4.4% | $108.90m |
Company Profile
Adaptimmune Therapeutics Plc is a clinical stage biopharmaceutical company, which focuses on novel cancer immunotherapy products based on T-cell receptor platform. Its TCR platform targets NY-ESO-1 cancer antigen. The company was founded in December 2014 and is headquartered in Oxford, the United Kingdom.